Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2011-3-18
pubmed:abstractText
Transarterial chemoembolization (TACE) has long been used as a palliative therapy for unresectable hepatocellular carcinoma (HCC). High-dose hepatic arterial infusion chemotherapy (HAIC) has showed favorable outcomes in patients with intractable, advanced HCC. The aim of this study was to compare the effectiveness and safety of high-dose HAIC and conventional TACE using doxorubicin for advanced HCC.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1738-222X
pubmed:author
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
355-61
pubmed:meshHeading
pubmed-meshheading:21415578-Antibiotics, Antineoplastic, pubmed-meshheading:21415578-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:21415578-Carcinoma, Hepatocellular, pubmed-meshheading:21415578-Chemoembolization, Therapeutic, pubmed-meshheading:21415578-Cisplatin, pubmed-meshheading:21415578-Doxorubicin, pubmed-meshheading:21415578-Fluorouracil, pubmed-meshheading:21415578-Humans, pubmed-meshheading:21415578-Infusions, Intra-Arterial, pubmed-meshheading:21415578-Liver Neoplasms, pubmed-meshheading:21415578-Magnetic Resonance Imaging, pubmed-meshheading:21415578-Prospective Studies, pubmed-meshheading:21415578-Retrospective Studies, pubmed-meshheading:21415578-Severity of Illness Index, pubmed-meshheading:21415578-Survival Rate, pubmed-meshheading:21415578-Tomography, X-Ray Computed
pubmed:year
2010
pubmed:articleTitle
A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.
pubmed:affiliation
Department of Internal Medicine, The Catholic University of Korea School of Medicine, Seoul, Korea.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't, Multicenter Study